VPAC2 CRE-Luc CHO
CBP71567
詢 價(jià)
索取Protocol
產(chǎn)品描述
產(chǎn)品數(shù)據(jù)庫
| I. Background | |
| N/A | |
| II. Description | |
| N/A | |
| III. Introduction | |
| Host Cell: |
CHO |
| Stability: | 20 passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Freeze Medium: | 90% FBS+10% DMSO |
| Culture Medium: | F12K+10%FBS +5 μg/ml Puromycin+600 μg/ml Hygromycin B |
| Mycoplasma Status: | Negative |
| Storage: | Liquid nitrogen immediately upon delivery |
| Application(s): |
Functional assay for VPAC2 Receptor |
| Assay Format: | Gs |
| IV. Description of Host Cell Line | |
| Organism: | Hamster |
| Tissue: | Ovary |
| Morphology: | Epithelial |
| Growth Properties: | Adherent |
V. Representative Data![]() Figure 1. Recombinant VPAC2 CRE-Luc CHO stably expressing VPAC2. ![]() Figure 2. Dose Response of Agonists in VPAC2 CRE-Luc CHO(C5). ![]() Figure 3.Inhibition of PACAP 1-38 induced Reporter Activity by PACAP38 Neutralization Ab in VPAC2 CRE-Luc CHO(C5). |
|
|
|
|


